Biotech

The Medicines Company to Participate in the 2012 Barclays Capital Global Healthcare Conference

PARSIPPANY, NJ: ...

Cornerstone Therapeutics Divests Its Anti-Infective Assets

CARY, NC: Continues Focused Execution of Strategic Plan Completes Migration From Primary Care Market Reaffirms Hospital and Related Specialty Markets as Platform for Future Growth ...

Proteonomix Announces a Private Placement of $3.8 Million

MOUNTAINSIDE, NJ: ...

ProMetic Secures a $2.5 Million Follow on Agreement

LAVAL, QUEBEC, CANADA: - Signing triggers $0.8 million upfront payment ...

Miraculins Outlines Details of PreVu 510(k) FDA Clearance

WINNIPEG, MANITOBA: U.S. Market Holds Significant Potential for Non-Invasive Skin Cholesterol Test ...

The Alliance for Regenerative Medicine Statement on Use of Cell Therapies Not Approved by the Federal Drug Administration

WASHINGTON, DC: ...

SOHM Inc. Enlists Maxim Group as Financial Advisor and Investment Banker

BUENA PARK, CA: ...

Cytokinetics Announces Fundamental Research in the Field of Fast Skeletal Muscle Activation Published in the Journal Nature Medicine

SOUTH SAN FRANCISCO, CA: Novel Mechanistic Approach to Directly Modulating Muscle Contractility May Represent a Promising Strategy to Treat Serious Neuromuscular Disorders ...

Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2011 Conference Call

CARY, NC: ...

Warnex Extends Maturity Date of its Outstanding Debentures and Provides Update on its Listing Status

LAVAL, QUEBEC: ...